Lawrence P. Guiheen, Director at ADMA BIOLOGICS, INC. (ADMA), bought 5,000 shares at $8.50 ($43K) on 2013-10-22, disclosed to the SEC on 2013-10-23.
Open-market purchase of $42k ADMA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ADMA | SELL | 2024-09-11 | $166K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $70K | — | Filing → |
| ADMA | BUY | 2019-05-21 | $100K | — | Filing → |